Search
Search Constraints
You searched for: Is Part Of Seizure. Volume 83(2020)Limit your search
- 616.853 49
- Electronic journals 49
- Epilepsy -- Periodicals 49
- Seizures -- Periodicals 49
- Épilepsie -- Périodiques 49
- AE autoimmune encephalitis -- AED antiepileptic drug -- AEEG 24-h ambulatory EEG -- AMPAR alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor -- CASPR2 contactin-associated protein-like 2 -- CNS central nervous system -- CSs clinical seizures -- DRE drug-resistant epilepsy -- CSF cerebrospinal fluid -- EDE electrodecremental event -- FBDS faciobrachial dystonic seizures -- GABAR γ-aminobutyric acid receptor -- GAD65 glutamic acid decarboxylase 65 -- GPDs generalized periodic discharges -- HV hyperventilation -- IEDs interictal epileptiform discharges -- LGI1 leucine-rich glioma-inactivated 1 -- mTL mesial temporal lobe -- MTLE mesial temporal lobe epilepsy -- NCSE non convulsive status epilepticus -- NMDAR N-methyl-D-aspartate receptor -- NREM Non Rapid Eye Movement -- SCSs subclinical seizures -- SOX1 SRY-Box Transcription Factor 1 -- SSW sequential spike/spike-and-slow wave -- TLE temporal lobe epilepsy -- VEEG video-EEG 1
- AED antiepileptic drug -- CBZ carbamazepine -- CBZ-CR carbamazepine controlled-release formulation -- CBZ-IR carbamazepine immediate-release formulation -- IPD individual participant data -- OXC oxcarbazepine -- RCT randomized clinical trials -- QOL quality of life -- RWE real-world evidence 1
- AEP Australian Epilepsy Project -- ASM antiseizure medication -- TeleNP teleneuropsychology 1
- AMPA receptor antagonist -- Anti-seizure drug -- Real-world study -- Seizure freedom -- Non-refractory epilepsy -- Rational polytherapy 1
- AMPA α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid -- ASD antiseizure drug -- BRV brivaracetam -- BZD benzodiazepines -- CBZ carbamazepine -- ESL eslicarbazepine acetate -- GBP gabapentin -- IGE idiopathic generalized epilepsy -- LCM lacosamide -- LEV levetiracetam -- LTG lamotrigine -- OXC oxcarbazepine -- PB phenobarbital -- PER perampanel -- PGB pregabalin -- PHT phenytoin -- SCB sodium-channel blockers -- TPM topiramate -- VPA valproic acid -- ZNS zonisamide 1